Nanotechnology platforms for cancer immunotherapy.

Area of Science:

• Nanomedicine
• Oncologic Disease
• Immunotherapy

Background:

• Cancer immunotherapy represents a paradigm shift from direct tumor cell targeting to harnessing the host immune system.
• Nanoparticles offer a versatile platform for delivering immunomodulatory agents, activating immune cells, and modifying the tumor microenvironment.
• Recent years have seen significant research into nanoparticle-based cancer immunotherapies.

Purpose of the Study:

• To review recent advances in nanoparticle-based platforms for cancer immunotherapy.
• To summarize delivery systems incorporating various immune-modulating agents.
• To introduce combinational nanoparticle-based cancer immunotherapies.

Main Methods:

• Focus on naturally derived and synthetic nanoparticles.
• Summarize delivery systems for peptides, nucleic acids, immune checkpoint inhibitors, and immunostimulating agents.
• Review combinational approaches like photo-immunotherapy and chemo-immunotherapy.

Main Results:

• Nanoparticle-incorporated cancer immunotherapy shows promise as a potent treatment modality.
• Various nanoparticle platforms are being explored for enhanced drug delivery and immune modulation.
• Combinational strategies, including photo- and chemo-immunotherapy, are emerging.

Conclusions:

• Nanoparticle-based cancer immunotherapy is a highly promising therapeutic approach.
• Further research is essential to address safety concerns and improve efficacy for clinical translation.
• Nanomedicine holds significant potential for advancing oncologic disease treatment.